Global Urinary Incontinence Market Size to Reach USD 4.53 Billion in 2028

The global urinary incontinence market size is expected to reach USD 4.53 Billion in 2028 at a CAGR of 7.6% during the forecast period, according to the latest report by Reports and Data. Increasing incidence of urinary incontinence (UI) among women across the globe, technological advancements in urinary incontinence devices, improvements in health policies and insurance coverage, and growing awareness among patients regarding severity of the medical condition are key factors expected to drive market revenue growth over the forecast period. In addition, development of advanced surgical and non-invasive therapies, availability of wide range of treatment modalities for urinary incontinence, and rising number of initiatives to raise awareness of UI are some other key factors expected to further fuel revenue growth of the market going ahead.

Urinary incontinence is a common and distressing medical condition and is defined as involuntary or abnormal urine loss caused due to lower urinary tract dysfunction, chronic conditions, or medications. Urinary incontinence can have serious negative effects on physical function, psychological health, and quality of life for patients. It can limit mobility of patients and social interactions and can lead to depression in severe cases. Neglected urinary incontinence can lead to systemic infections, skin problems, and skin wounds, which further adds other physical morbidities to patients who are already suffering from numerous symptoms. Urinary incontinence is recognized as a priority health issue by the World Health Organization and has emphasized the need for proper attention from all healthcare providers to develop effective management techniques for urinary incontinence. It also poses a significant economic burden to the individual and healthcare system, and this has further boosted demand for robust treatment options, UI-specific tools to enhance patient outcomes, and introduction of advanced surgical interventions. This can, in turn, fuel revenue growth of the market going ahead.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2741

Treatment of incontinence can vary with the type of incontinence, which makes it important to accurately identify the specific type of incontinence. Urinary incontinence is classified into three main types: stress UI, urge UI, and mixed UI. In recent years, treatment options for stress and urge urinary incontinence have advanced and aim to prevent involuntary loss of urine caused due to increased intra-abdominal pressure occurring during physical activity. Advancements in and rapid adoption of non-surgical therapies such as behavioral therapy and drug therapy are some other factors expected to drive market growth. However, lack of awareness about available treatment modalities, absence of favorable reimbursement policies in developing countries, and social stigma surrounding this condition are some key factors that can hamper market growth to a certain extent going ahead.

Some Key Highlights from the Report:

  • Stress incontinence segment is expected to account for largest revenue share over the forecast period, attributable to increasing incidence of stress urinary incontinence among women, advancements in conservative therapies for stress UI, and rise in number of people opting for treatment for stress incontinence.
  • Neuromodulation segment is expected to dominate other devices segments in terms of revenue growth over the forecast period, attributable to increasing adoption of neuromodulative therapies for treatment of urinary incontinence, technological advancements in neuromodulation devices, and increasing importance of neuromodulation therapies in urology.
  • Hospital segment is expected to register significant revenue growth over the forecast period, attributable to increasing availability of advanced treatment approaches such as neuromodulation devices in hospital settings, rising number of patients opting for surgical therapies for urinary incontinence, and availability of skilled professionals.
  • North America is expected to account for largest revenue share over the forecast period, attributable to increasing prevalence of urinary incontinence in the United States and Canada, growing geriatric population, rising number of regulatory approvals for incontinence devices, growing popularity of at-home treatments, and favorable reimbursement policies in the region.

  Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product & service portfolio. The Urinary Incontinence market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.

Leading companies operating in the market are:

  • Covidien Plc (Medtronic)
  • Coloplast
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • ConvaTec Group Plc
  • Ethicon, Inc.
  • Caldera Medical Inc.
  • Cook Medical
  • Prosurg, Inc.
  • Cogentix Medical Inc.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2741

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

  Urinary Incontinence Market Segmentation:

Type Outlook:

  • Urge Incontinence
  • Overflow Incontinence
  • Stress Incontinence
  • Functional Incontinence
  • Mixed Urinary Incontinence
  • Total Incontinence
  • Others

Device Outlook:

  • Electrical Stimulation Devices
    • Non-implantable
    • Implantable
  • Urethral Bulking Agents
  • Urinary Catheters
    • Foley
      • Antimicrobial Foley Catheters
    • Suprapubic
    • Intermittent
  • Neuromodulation Devices
  • Others

End-use Outlook:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Use
  • Others

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)

Some essential purposes of the Urinary Incontinence market research report:

  • Vital Developments: Custom investigation provides critical improvements to the Urinary Incontinence market, including R&D, new item shipment, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working in the market on a global scale and regional.
  • Market Characteristics: The report contains Urinary Incontinence market highlights, income, limit, limit utilization rate, value, net, creation rate, generation, utilization, import, trade, supply, demand, cost, part of the industry in general, CAGR, and gross margin. Likewise, the market report offers an exhaustive investigation of the elements and their most recent patterns, along with Service market fragments and subsections.
  • Investigative Tools: This market report incorporates the accurately considered and evaluated information of the major established players and their extension into the Urinary Incontinence market by methods. Systematic tools and methodologies, for example, Porter’s Five Powers Investigation, Possibilities Study, and numerous other statistical investigation methods have been used to analyze the development of the key players working in the Urinary Incontinence market.
  • Convincingly, the Urinary Incontinence report will give you an unmistakable perspective on every single market reality without the need to allude to some other research report or source of information. This report will provide all of you with the realities about the past, present, and eventual fate of the Urinary Incontinence market.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2741

Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

Neurovascular Devices Market @ https://www.biospace.com/article/neurovascular-devices-market-size-worth-usd-3-60-billion-by-2028-/

In vivo CRO Market @ https://www.biospace.com/article/in-vivo-cro-market-size-to-hit-usd-6-44-billion-in-2028-/

Hyperbaric Oxygen Therapy (HBOT) Devices/Equipment Market @ https://www.biospace.com/article/hyperbaric-oxygen-therapy-hbot-devices-equipment-market-expected-to-reach-usd-4-65-billion-in-2028-/

Electrosurgical/Electrosurgery Devices Market @ https://www.biospace.com/article/electrosurgical-electrosurgery-devices-market-is-expected-to-reach-usd-8-17-billion-by-2028-/

  About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs